Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MARVELD3 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-05 |
mRNA | ZNF155 | CCLE | pan-cancer | AAC | 0.18 | 8e-05 |
mRNA | STK39 | CCLE | pan-cancer | AAC | -0.18 | 8e-05 |
mRNA | ELMO3 | CCLE | pan-cancer | AAC | 0.22 | 9e-05 |
mRNA | EFNA1 | CCLE | pan-cancer | AAC | 0.23 | 9e-05 |
mRNA | SH3BP5L | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | UXT | CCLE | pan-cancer | AAC | -0.19 | 9e-05 |
mRNA | LAMP3 | CCLE | pan-cancer | AAC | 0.19 | 9e-05 |
mRNA | DSG2 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-05 |
mRNA | C17orf51 | CCLE | pan-cancer | AAC | -0.18 | 9e-05 |